Afatinib plus cetuximab delays resistance compared to single agent erlotinib or afatinib in mouse models of TKI-naive EGFR L858R-induced lung adenocarcinoma
Pirazzoli, V.; Ayeni, D.; Meador, C. B.; Sanganahalli, B.; Hyder, F.; de Stanchina, E.; Goldberg, S. B.; Pao, W.; Politi, K.
- 期刊名称Clinical Cancer Research
- 作者Pirazzoli, V.; Ayeni, D.; Meador, C. B.; Sanganahalli, B.; Hyder, F.; de Stanchina, E.; Goldberg, S. B.; Pao, W.; Politi, K.
- 印刷ISSN1078-0432
- 电子ISSN1557-3265
- 文件大小1144.73KB
- 发表时间2015-09-04
- DOI10.1158/1078-0432.CCR-15-0620